A carregar...
Overdetection, overtreatment and costs in prostate-specific antigen screening for prostate cancer
BACKGROUND: Prostate cancer screening with prostate-specific antigen (PSA) has shown to reduce prostate cancer mortality in the European Randomised study of Screening for Prostate Cancer (ERSPC) trial. Overdetection and overtreatment are substantial unfavourable side effects with consequent healthca...
Na minha lista:
| Main Authors: | , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Nature Publishing Group
2009
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2788248/ https://ncbi.nlm.nih.gov/pubmed/19904272 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6605422 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|